What is Alzheimer’s

Alzheimer’s is the most common form of dementia, accounting for 50-80% of all cases, and leads to loss of cognitive functioning—thinking, remembering, and reasoning. The disease is named after Dr. Alois Alzheimer, who noticed changes in the brain tissue of a woman who had died of an unusual mental illness and exhibited symptoms of memory loss, language problems, and unpredictable behavior. It is the sixth leading cause of death in the U.S. In a majority of cases, the symptoms first appear after the age of 60 years. Affected individuals live for an average of 8 years after they first begin to show symptoms, but can survive for anywhere between 4  to 20 years, depending upon their age and health condition.

The symptoms develop slowly and gradually worsen to such an extent that severe loss of memory and other intellectual abilities makes it impossible for the person to carry out simplest tasks of daily living. In the early stages, there is mild memory loss, but as the disease advances, the symptoms become increasingly severe and include disorientation, changes in mood and behavior, confusion regarding events, time and place, paranoid delusions about family, friends and caregivers, serious memory loss, and difficulty in speaking, swallowing and walking.


What Causes Alzheimer’s

Just like the human body, the brain also changes along with age. As we age, there can be some slow down in thinking and difficulty in remembering. However, serious memory loss, confusion and major behavioral changes could indicate that nerve cells (neurons) in the brain may be failing. There are over 100 billion nerve cells in the human brain and each nerve cell connects with others to form communication networks. Some groups of nerve cells are involved in thinking, learning and remembering, while others help to see, hear and smell. Alzheimer’s disrupts critical metabolic processes that keep nerve cells healthy, causing abnormal deposits of proteins form amyloid plaques and tau tangles throughout the brain. As a result, once-healthy nerve cells lose connections with others and begin to work less efficiently. As the damage spreads, nerve cells completely lose their ability to do their job and finally die, leading to loss of memory, changes in personality and behavior, difficulty in carrying out daily activities, and other features of the disease. As more neurons die, the affected regions of the brain begin to shrink in a process called brain atrophy and by the final stage of the disease, the damage becomes widespread, with brain tissue shrinking significantly.


Cerebra’s Treatment for Alzheimer’s

The current treatments for Alzheimer’s can only slow down its progression and help manage symptoms in some people, though there is no cure for this devastating disease. Cerebra’s deep desire to find safe, non-invasive, technology-based solutions to crippling neurological disorders, for whom, traditional medical science is unable to offer concrete solutions, has led to Cerebra PhotoBioStim (CPBS) technology, which is a potent weapon against deadly neurological diseases, such as Alzheimer’s. The rising amyloid beta levels in the form of plaque around nerve cells can be reduced and the falling levels of tau proteins in nerve cells can be enhanced through CPBS. Using cold coherent lights to regenerate brain cells that are overpowered by amyloid plaques, and at the same time enhance nerve cells’ protein synthesis, thus increasing levels of tau proteins, CPBS therapy ensures the sustainability of brain cells and their adaptability to changing biochemical nature of cells, as well as acts as a neuroprotector from additional damage due to loss of brain connections. This completely alters the outcomes for adults suffering from Alzheimer’s, stroke, brain trauma, Multiple Sclerosis, Parkinson’s, depression, etc.

Cerebra’s suite of brain enhancement and regeneration technologies also includes Cerebra TurboBrain (CTB), which is an effective, non-intrusive and drugless way of increasing cerebral blood flow to enhance cognitive abilities. By increasing cerebral blood flow, CTB increases the rate of capillary formation – Angiogenesis – and improves extensive synaptic connections among neurons through the process of Synaptogenesis – thereby drastically improving thinking, memory, focus and attention. CTB accelerates the production of stem-cells (master cells with the ability to grow into any one of the body’s more than 200 cell types) in the brain, which allows for the renewal and repair of any body tissue, including the brain.

Both CPBS and CTB offer great potential in the resolution of adult disorders, such as stroke, traumatic brain injury, depression, schizophrenia, Alzheimer’s, dementia, etc., and are already delivering promising results for affected people across Asia, including Mumbai and New Delhi. Please visit the Scientific Research section in the website to read about the vast amount of studies that is being done on CPBS and CTB technologies.


Why Early Intervention Is Important In Treatment for Alzheimer’s

Intervening aggressively at an early stage is crucial in all neurological diseases, as the brain’s abilities declines sharply with each passing day. So, the earlier the intervention, the better the chances of arresting the decline in mental skills, which, once lost completely, may be almost impossible to regain.

Alzheimer’s is a life-changing event that affects not only the patients themselves, but also their family members and caregivers. Since it is a progressive brain disease, early intervention is vital in order to improve the patient’s cognitive functions and quality of life, as well as reduce the caregiver’s burden. Timely treatment with CPBS and CTB training before irreversible brain loss occurs can slow or even stop the progression of symptoms.

Please visit the Success Stories section in the website to read heart-warming testimonials from Alzheimer’s patients and their caregivers of the remarkable benefits experienced after undergoing CPBS and CTB training.